关键词: Ozurdex, 黄斑水肿, 视网膜静脉阻塞, 糖尿病性黄斑水肿, 非感染性葡萄膜炎

Abstract:

Macular edema is one of the main causes of visual dysfunction in patients with fundus disease. Many factors cause the destruction of blood-retinal barrier and form macular edema, among which inflammation plays an important role in the formation of macular edema. In order to overcome the limitations of traditional intravitreous hormone injection, dexamethasone vitreous implant (Ozurdex) came into being. Its good clinical effect and unique drug delivery system provide a new choice for the treatment of macular edema. Ozurdex has good efficacy and safety in the theatment of macular edema caused by fundus diseases such as retinal vein occlusion, diabetic retinopathy and non-infective uveitis.(Int Rev Ophthalmol, 2020, 44：346-350)

Key words: Ozurdex, macular edema, retinal vein occlusion, diabetic macular edema, noninfectious uveitis